EXPERT COLLECTIONExplore our leading medical review series
Asia PacificDon [email protected]: +886 905 239 228
Australia & New ZealandKim [email protected]: +61 (0)3 8842 2404
ChinaGuangwei [email protected]: (8610) 58452820
IndiaNeeti [email protected]: +91 (11) 4315 5100
JapanYonoske [email protected] Tel: +81 (0)3 5244 5952
UK, Europe, Middle East & AfricaIan [email protected]: +44 (0)20 7017 6203
USA, Canada & South AmericaAshleigh [email protected]: +44 (0) 207 017 6350
Editorial ContactMary Yianni Publisher, Expert [email protected]: +44 (0)207 017 7783
Prices and Contact InformationFor information about the Taylor & Francis Expert Collection or other Medical journal products please contact your sales representative below.
Introducing the
The Taylor & Francis Expert Collection is the world’s largest series of review journals in research, development, and clinical medicine.
The Expert Collection is comprised of 29 peer-reviewed journals combining the well-established Expert Opinion and Expert Review series into one essential and comprehensive collection.
What makes the Expert Collection different? The Expert Collection combines the personal opinions of our expert authors who are all internationally recognized experts in their fields. They provide their insights about where research is now, where it should go next and how it should get there. In this respect, all Expert Collection reviews end with an expert opinion on expert commentary, not a conclusion.
The Expert Collection publishes:
• Reviews
• Editorials
• Original research
• Drug evaluations
• Treatment evaluations
• Clinical trial evaluations
• Technology evaluations
• Patent evaluations
• Key paper evaluations
In my opinion, the Expert Collection is the most relevant journal review series in the area of Pharmacology. The Expert Collection is a credible, topical, and scholarly resource that I have come to rely on in my role as a leader of international pharmacological studies. It is apparent that the peer review process is thorough and critical, and the editorial process is unparalleled in terms of author support.
Dr Roger McIntyre, University of Toronto
Editor-in-ChiefExpert Opinion on Drug Safety
‘‘
‘‘
The Expert Review journals
cover 18 different areas of clinical
medicine
The Expert Opinion journals cover the entire
R&D pipeline across 11 journals
DRUG DISCOVERY PRECLINICAL PHASE I PHASE II PHASE III LAUNCH
Expe
rt O
pini
on o
n
Ther
apeu
tic P
aten
tsEx
pert
Opi
nion
on
Dru
g D
isco
very
Expe
rt O
pini
on o
n
Biol
ogic
al T
hera
pyEx
pert
Opi
nion
on O
rpha
n D
rugs
Expe
rt O
pini
on o
n
Dru
g D
eliv
ery
Expe
rt O
pini
on o
n
Emer
ging
Dru
gs
Expe
rt O
pini
on o
n
Phar
mac
othe
rapy
Expe
rt O
pini
on o
n
Ther
apeu
tic T
arge
ts
Expe
rt O
pini
on o
n
Inve
stig
atio
nal D
rugs
Expe
rt O
pini
on o
n
Dru
g M
etab
olis
m
& To
xico
logy
Expe
rt O
pini
on
on D
rug
Safe
ty
Anticancer T
herapy
Anti-infective T
herapy
Card
iovascular T
herapy
Clinical Im
muno
log
y
Clinical P
harmaco
log
y
End
ocrino
log
y & M
etabo
lism
Gastro
enterolo
gy &
Hep
atolo
gy
Hem
atolo
gy
Med
ical Devices
Mo
lecular Diag
nostics
Neuro
therapeutics
Op
hthalmo
log
y
Pharm
acoeco
nom
ics &
Outco
mes R
esearch
Pro
teom
ics
Precisio
n Med
icine &
Drug
Develo
pm
ent
Quality o
f Life in Cancer C
are
Resp
iratory M
edicine
Vaccines
EXPERT COLLECTION
The Expert Review Series
Expert Review of Anticancer Therapy
2.094Appraisal and commentary on the major trends in cancer care and highlights on the performance of new therapeutic and diagnostic approaches.
Yes
Expert Review of Anti-infective Therapy
3.542 Therapeutics and diagnostics in the treatment of infectious disease.
Yes
Expert Review of Cardiovascular Therapy
–Evaluation of new diagnostic and therapeutic cardiovascular modalities.
Yes
Expert Review of Clinical Immunology
2.596 Performance of new therapeutic and diagnostic modalities in clinical immunology.
Yes
Expert Review of Clinical Pharmacology
2.488 Critical analysis of safety, tolerability, efficacy and therapeutic applications of new therapies.
Yes
Expert Review of Endocrinology & Metabolism
–Extensive coverage of research and clinical advancements in the field of endocrine control, metabolism and novel therapeutics.
–
Journal
Impact FactorScope
Medline indexed?
Expert Review of Gastroenterology & Hepatology
2.796 Latest advances in pathological, biochemical and physiological understanding of diseases affecting the gastrointestinal tract and liver.
Yes
Expert Review of Hematology
2.439
Commentary and analysis to elucidate best clinical practice in hematology. Yes
Expert Review of Medical Devices
1.762Commentary, analysis, and debate on the development, testing, and clinical use of devices.
Yes
Expert Review of Molecular Diagnostics
3.333 Latest advances in the field of molecular diagnostics including the detection and monitoring of the molecular causes of disease.
Yes
Expert Review of Neurotherapeutics
2.578 Analysis of drugs and medicines in clinical neurology and neuropsychiatry.
Yes
Expert Review of Ophthalmology
–Commentary and debate on current and emerging approaches in ocular medicine.
–
Journal
Impact FactorScope
Medline indexed?
Expert Review of Pharmacoeconomics & Outcomes Research
1.631 Cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches.
Yes
Expert Review of Proteomics
3.456 Technologies, methods, and discoveries from the field of proteomics.
Yes
Expert Review of Precision Medicine & Drug Development
–Original research and review articles covering the development and clinical application of medicine to be used in a personalized therapy setting.
–
Expert Review of Quality of Life in Cancer Care
–Discussion of the major topics of concern in the quality of life of cancer patients, and how best to manage these issues in the clinical setting.
–
Expert Review of Respiratory Medicine
2.176 Commentary from international leaders in the fields of obstructive, restrictive, vascular, and infectious respiratory diseases.
Yes
Expert Review of Vaccines
4.222 Analysis of the clinical effectiveness of new vaccines plus new developments in vaccine technology.
Yes
Journal
Impact FactorScope
Medline indexed?
The Expert Opinion Series
Expert Opinion on Therapeutic Patents
4.626 Technological advances and developments in pharmaceutical patents, with a strong medicinal chemistry focus.
Yes
Expert Opinion on Drug Discovery
3.484 Novel technologies involved in the drug discovery process, leading to new leads and reduced attrition rates.
Yes
Expert Opinion on Therapeutic Targets
4.798 Novel molecular drug targets and their potential for drug discovery/disease treatment.
Yes
Expert Opinion on Investigational Drugs
4.408 Drugs and drug classes in early clinical development.
Yes
Expert Opinion on Biological Therapy
3.438 Discovery, development, and clinical application of vaccines, antibodies, stem cells, genetic therapies, and hormone or protein-based therapies.
Yes
Expert Opinion on Orphan Drugs
0.464 Research and development on rare diseases and orphan drugs.
–
Journal
Impact FactorScope
Medline indexed?
Expert Opinion on Drug Delivery
5.434 Drug delivery technologies and new drug formulations.
Yes
Expert Opinion on Drug Metabolism & Toxicology
2.598 Approaches to the ADME-Tox arena, as well as metabolic, pharmacokinetic, and toxicological issues relating to specific drugs or drug classes.
Yes
Expert Opinion on Emerging Drugs
2.120 Focus on drugs coming up through the pipeline, analysis on what the next drugs to come on to the market are likely to be and their impact on disease management.
Yes
Expert Opinion on Pharmacotherapy
3.543 Newly approved or near to launch drugs and drug classes.
Yes
Expert Opinion on Drug Safety
2.896Post-marketing and pharmacovigilance studies as well as the safety and adverse event profiles of marketed drugs.
Yes
Journal
Impact FactorScope
Medline indexed?
DRUG DISCOVERY PRECLINICAL PHASE I
PHASE II PHASE III LAUNCH
* Impact Factors from 2015 Journal Citation Reports® (Thomson Reuters, 2016)
Our Ethics
Our content influences patient care decisions. With this comes enormous responsibility to safeguard the medical community from fraudulent or misguiding data. We not only follow industry standards of publication ethics, but have taken a leading role in pushing them further.
In 2003, our sister journal, Current Medical Research & Opinion (CMRO) published the first Good Publication Practice (GPP) guidelines. The aim of the guidelines was to ensure that clinical trials sponsored by pharmaceutical companies were published in a responsible and ethical manner. The guidelines quickly established a common standard for all industry-sponsored research and continue to do so today.
We continue to take an active role in organizations that endorse publication ethics. In January 2010, we joined COPE. Supported by our vast network of industry experts, we remain vigilant against publication abuses in every title that we publish.
Committee on Publication Ethics (COPE) The Committee on Publication Ethics (COPE) is a charity registered in the UK. With over 7,000 members, it is concerned with the integrity of peer-reviewed publications in science, particularly biomedicine. COPE provides a forum for publishers and editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
Uniform Requirements for Manuscripts Submitted to Biomedical Journals Created by the International Committee of Medical Journal Editors (ICMJE), the Uniform Requirements address the ethical principles related to the process of evaluating, improving, and publishing manuscripts in biomedical journals, and the relationship among editors and authors, peer reviewers, and the media.
A copy of the most recent Uniform Requirements can be found at www.icjme.org.
All Expert Collection titles are members
of the Committee on Publication Ethics
(COPE)
All Expert Collection titles are independently
peer-reviewed and require full author
disclosures
The Expert Collection adheres to
the principles of Uniform Requirements for Manuscripts
Submitted in Biomedical Journals, prepared by
the ICMJE and the NLM guidelines for published
articles and supplements
Quick Facts
Subscription options for the Expert CollectionExpert Review CollectionA package including 18 of the Expert Review series journals.
Expert Opinion CollectionA package including 11 of the Expert Opinion series journals.
Title-by-title subscriptionsTailor your collection on a title-by-title basis. You can choose from combined print and online access or opt for online only access.
Discover the Taylor & Francis Medical Library The Medical Library provides online access to a broad range of journal content in over 30 key subject areas. This collection includes current content from over 200 peer-reviewed academic journals.
HIGHLIGHTS…
Current Medical
Research & Opinion
Postgraduate Medicine
Leukemia & Lymphoma
Medical Teacher